cyclosporine has been researched along with Familial Combined Hyperlipidemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar-Salinas, CA; Alberú, J; Arellano, A; Correa-Rotter, R; Díaz-Polanco, A; Gómez Pérez, FJ; Macias, N; Ordóñez, ML; Quintana, E; Ramírez, E; Velásquez-Alva, C | 1 |
1 other study(ies) available for cyclosporine and Familial Combined Hyperlipidemia
Article | Year |
---|---|
Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
Topics: Adult; Apolipoproteins E; Body Composition; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraindications; Cyclosporine; Diet; Female; Genetic Predisposition to Disease; Graft Survival; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Mexico; Sex Factors; Surveys and Questionnaires | 2002 |